Takeda Pharmaceutical
TAK
#476
Rank
A$66.70 B
Marketcap
$21.04
Share price
-0.37%
Change (1 day)
2.14%
Change (1 year)

Operating Margin for Takeda Pharmaceutical (TAK)

Operating Margin as of December 2024 (TTM): 9.08%

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 9.08%. At the end of 2023 the company had an Operating Margin of 9.31%.

Operating Margin history for Takeda Pharmaceutical from 2009 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
20239.31%9.86%
20228.48%-25.98%
202111.45%-720.42%
2020-1.85%-130.34%
20196.08%-50.4%
201812.27%48.23%
20178.28%24.09%
20166.67%-181.53%
2015-8.18%-187.12%
20149.39%9.87%
20138.55%-48.92%
201216.73%-36.08%
201126.18%-7.71%
201028.37%9.49%
200925.91%-38.25%
200841.96%-12.43%
200747.92%12.14%
200642.73%8.78%
200539.28%-4.35%
200441.07%-0.54%
200341.29%11.12%
200237.15%36.07%
200127.30%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
17.68% 94.71%๐Ÿ‡บ๐Ÿ‡ธ USA
15.40% 69.60%๐Ÿ‡ซ๐Ÿ‡ท France
1.80%-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
25.49% 180.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-30.69%-438.00%๐Ÿ‡บ๐Ÿ‡ธ USA
24.37% 168.39%๐Ÿ‡ฎ๐Ÿ‡ณ India
14.38% 58.37%๐Ÿ‡บ๐Ÿ‡ธ USA
10.36% 14.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
3.14%-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.